Global Market Bulletin
  • Home
  • Stock Market News
  • Investing
  • Economy
  • CEO Interviews
  • Contact Us
No Result
View All Result
SUBSCRIBE
Global Market Bulletin
  • Home
  • Stock Market News
  • Investing
  • Economy
  • CEO Interviews
  • Contact Us
No Result
View All Result
Global Market Bulletin
No Result
View All Result
Home Stock Market News

Top 10 Stocks Jim Cramer Is Watching Right Now

by Global Market Bulletin
February 27, 2026
in Stock Market News
0
Top 10 Stocks Jim Cramer Is Watching Right Now

Top 10 Stocks Jim Cramer Is Watching Right Now

77
SHARES
167
VIEWS
Share on FacebookShare on Twitter

4. Marriott International Inc. (NASDAQ:MAR)

Marriott International Inc. (NASDAQ: MAR), recently trading near $342.58, continues to demonstrate why it remains a cornerstone travel stock in a resilient global tourism cycle. Despite a modest pullback, the company has advanced meaningfully since late October, supported by a strong quarterly earnings report and constructive commentary from management reinforcing demand stability across both leisure and business travel. Television host Jim Cramer has publicly reiterated his bullish stance, stating that he likes Marriott for travel and believes the travel bull market remains intact, emphasizing that macro noise, including government shutdown concerns, has not materially derailed the company’s momentum.

You might also like

5 Most Profitable Energy Stocks to Buy in 2026

10 Most Profitable Energy Stocks to Buy in 2026

Here’s What Makes Iovance Biotherapeutics (IOVA) a Smart Long-Term Buy

Marriott International, the world’s largest hotel operator by room count, benefits from a powerful asset-light business model built on franchising and management contracts, which drive high-margin fee revenue and robust free cash flow. Its diversified portfolio spans luxury, premium, select-service, and extended-stay brands, giving it exposure to multiple demand segments across geographies. The company’s loyalty ecosystem, Marriott Bonvoy, further strengthens pricing power and occupancy resilience by deepening customer engagement and repeat bookings, a key differentiator in the competitive hospitality industry.

Recent earnings highlighted sustained RevPAR growth and disciplined cost management, while the company’s CFO underscored that leisure travel demand has held up exactly as expected throughout the year. Although temporary disruptions such as government shutdown headlines created some business travel noise, management expressed confidence in underlying demand trends. This stability, combined with Marriott’s global scale and development pipeline, positions MAR to capitalize on continued international travel recovery and corporate travel normalization.

From a valuation and capital allocation perspective, Marriott’s strong balance sheet, consistent share repurchases, and dividend growth reinforce its profile as a high-quality consumer discretionary stock. As travel demand remains structurally supported by pent-up consumer spending, experiential consumption trends, and global mobility normalization, Marriott stands out as a premium hospitality investment. Cramer’s endorsement reflects the broader narrative that the travel bull market is alive, and Marriott, with its brand strength, operating leverage, and global footprint, remains class-leading within the hotel and leisure sector. For investors seeking exposure to durable travel growth, brand dominance, and cash-generative asset-light economics, Marriott International represents a compelling long-term holding within the travel and hospitality industry.

Click next to see the following stock...

Page 5 of 8
Prev1...456...8Next
Tags: American Express Company (NYSE:AXP)Arista Networks Inc (NYSE:ANET)Marriott International Inc. (NASDAQ:MAR)NVIDIA Corporation (NASDAQ:NVDA)Salesforce Inc. (NYSE:CRM)Snowflake Inc. (NYSE:SNOW)The TJX Companies Inc. (NYSE:TJX)Top 10 Stocks Jim Cramer Is Watching Right NowVisa Inc. (NYSE:V)Wells Fargo & Company (NYSE:WFC)Yum! Brands Inc. (NYSE:YUM)
Share31Tweet19

Global Market Bulletin

Global Market Bulletin is a leading provider of stock market updates, economic news, and personalized investing guides. Our team brings you the latest global financial information to help you make smart investment decisions. About the Editorial Team Our editorial team consists of financial experts and seasoned market analysts who bring decades of experience to our coverage. With a commitment to unbiased reporting, our team ensures that every article is backed by thorough research and delivers accurate financial insights.

Recommended For You

5 Most Profitable Energy Stocks to Buy in 2026

by Global Market Bulletin
June 12, 2026
0
5 Most Profitable Energy Stocks to Buy in 2026

In this article, we break down the 5 Most Profitable Energy Stocks to Buy in 2026. For investors looking for the complete list, you can explore our full...

Read moreDetails

10 Most Profitable Energy Stocks to Buy in 2026

by Global Market Bulletin
June 12, 2026
0
10 Most Profitable Energy Stocks to Buy in 2026

In this article, we will take a look at the 10 Most Profitable Energy Stocks to Buy in 2026. Every market cycle has its surprise winner, and in...

Read moreDetails

Here’s What Makes Iovance Biotherapeutics (IOVA) a Smart Long-Term Buy

by Global Market Bulletin
June 6, 2026
0
Here’s What Makes Iovance Biotherapeutics (IOVA) a Smart Long-Term Buy

We recently published our article Top 5 Heavily Shorted Small-Cap and Mid-Cap Stocks to Buy Today. To read the full story, you can go directly to  Top 10...

Read moreDetails

Is Capricor Therapeutics (CAPR) a Smart Biotech Stock to Buy Before Its Next Catalyst?

by Global Market Bulletin
June 6, 2026
0
Is Capricor Therapeutics (CAPR) a Smart Biotech Stock to Buy Before Its Next Catalyst?

We recently published our article Top 5 Heavily Shorted Small-Cap and Mid-Cap Stocks to Buy Today. To read the full story, you can go directly to  Top 10...

Read moreDetails

Here’s What Makes ImmunityBio (IBRX) a High-Upside Biotech Stock Investors Should Watch Closely

by Global Market Bulletin
June 6, 2026
0
Here’s What Makes ImmunityBio (IBRX) a High-Upside Biotech Stock Investors Should Watch Closely

We recently published our article Top 5 Heavily Shorted Small-Cap and Mid-Cap Stocks to Buy Today. To read the full story, you can go directly to  Top 10...

Read moreDetails

Browse by Category

  • CEO Interviews
  • Economy
  • Investing
  • Stock Market News
  • Uncategorized

QUICK LINKS

  • Stock Market News
  • Investing
  • Economy
  • Contact Us
  • About Global Market Bulletin
  • Editorial Policy – Global Market Bulletin
  • Our Editorial Team

RECENT POSTS

  • 5 Most Profitable Energy Stocks to Buy in 2026
  • 10 Most Profitable Energy Stocks to Buy in 2026
  • Here’s What Makes Iovance Biotherapeutics (IOVA) a Smart Long-Term Buy

GET EMAIL MARKET UPDATES

Subscribe to our mailing list to receives daily updates direct to your inbox!
  • Privacy Policy
  • Terms and Conditions

© 2022 Global Market Bulletin. All Rights Reserved.

No Result
View All Result
  • Home
  • Stock Market News
  • Investing
  • Economy

© 2022 Global Market Bulletin. All Rights Reserved.

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?